1. Home >
  2. M&A >
  3. Spin Off >
  4. Veritas Genetics Exits Veritas Intercontinental

Investment Summary

Veritas Genetics Exits Veritas Intercontinental

On January 1, 2018, invested in life science company Veritas Intercontinental from Veritas Genetics

Investment Highlights
  • This is transaction in the Life Science sector.
  • This is transaction in Spain.
Investment Fate
  • Veritas Intercontinental was sold to a consortium of financial buyers in 2020.
  • Veritas Intercontinental was sold to a strategic buyer in 2022.

Investment Summary
Date 2018-01-01
Target Veritas Intercontinental
Sector Life Science
Sellers(s) Veritas Genetics
Deal Type Spin Off

Target

Veritas Intercontinental

Madrid, Spain
Veritas Intercontinental is a provider of whole genome and exome sequencing based analyses and genetic services for maternal-fetal medicine through large hospitals, specialized clinics and medical distributors. Veritas Intercontinental was founded in 2018 and is based in Madrid, Spain.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Seller(S) 1

SELLER

Veritas Genetics

Danvers, Massachusetts, United States
Category Company
Founded 2014
Sector Life Science
DESCRIPTION

Veritas Genetics is a provider of consumer genetics and whole genome sequencing services. Veritas Genetics was established in 2014 and is based in Danvers, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Spin Off M&A Deals 1 of 1
Country: Spain M&A 1 of 1
Year: 2018 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-03 Curoverse

Somerville, Massachusetts, United States

Curoverse, Inc. is a computing and bioinformatics company. Biomedical data analysis is transforming medicine. Curoverse, Inc. was established in 2010 and is based in Somerville, Massachusetts.

Buy -
Mergr

Solution for

Product

Company

Legal